Use of an antibody-drug conjugate targeting tissue factor to induce complete tumor regression in xenograft models with heterogeneous target expression.
Esther CW Breij
Employment or Leadership Position - Genmab
Stock Ownership - Genmab
David Satijn
Employment or Leadership Position - Genmab
Stock Ownership - Genmab
Sandra Verploegen
Employment or Leadership Position - Genmab
Stock Ownership - Genmab
Bart de Goeij
Employment or Leadership Position - Genmab
Stock Ownership - Genmab
Danita Schuurhuis
Employment or Leadership Position - Genmab
Stock Ownership - Genmab
Wim Bleeker
Employment or Leadership Position - Genmab
Stock Ownership - Genmab
Mischa Houtkamp
Employment or Leadership Position - Genmab
Stock Ownership - Genmab
Paul Parren
Employment or Leadership Position - Genmab
Stock Ownership - Genmab